Regenerative medicine in cardiology

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Emerging evidence indicates that cardiomyocytes can be regenerated from embryonic stem cells, adult mesenchymal stem cells, and cardiac side population cells (cardiac stem cells). When these cells were injected into diseased hearts, indices of cardiac function improved. There are ethical difficulties involved in the use of embryonic stem cells. The ratio of differentiation into cardiomyocytes is still relatively low at present. Transplantation of regenerated cardiomyocytes or stem cells, however, will become a future therapy for severe heart failure.

Original languageEnglish
Pages (from-to)454-458
Number of pages5
JournalNippon Geka Gakkai zasshi
Volume105
Issue number8
Publication statusPublished - 2004

Fingerprint

Regenerative Medicine
Cardiology
Cardiac Myocytes
Embryonic Stem Cells
Stem Cells
Side-Population Cells
Adult Stem Cells
Mesenchymal Stromal Cells
Heart Diseases
Heart Failure
Transplantation
Therapeutics

Cite this

Regenerative medicine in cardiology. / Manabe, Tomohiro; Fukuda, Keiichi.

In: Nippon Geka Gakkai zasshi, Vol. 105, No. 8, 2004, p. 454-458.

Research output: Contribution to journalArticle

@article{3ed6301c9cbf4a6a9929a58f8df00c86,
title = "Regenerative medicine in cardiology",
abstract = "Emerging evidence indicates that cardiomyocytes can be regenerated from embryonic stem cells, adult mesenchymal stem cells, and cardiac side population cells (cardiac stem cells). When these cells were injected into diseased hearts, indices of cardiac function improved. There are ethical difficulties involved in the use of embryonic stem cells. The ratio of differentiation into cardiomyocytes is still relatively low at present. Transplantation of regenerated cardiomyocytes or stem cells, however, will become a future therapy for severe heart failure.",
author = "Tomohiro Manabe and Keiichi Fukuda",
year = "2004",
language = "English",
volume = "105",
pages = "454--458",
journal = "Nihon Geka Gakkai zasshi",
issn = "0301-4894",
publisher = "Nihon Geka Gakkai",
number = "8",

}

TY - JOUR

T1 - Regenerative medicine in cardiology

AU - Manabe, Tomohiro

AU - Fukuda, Keiichi

PY - 2004

Y1 - 2004

N2 - Emerging evidence indicates that cardiomyocytes can be regenerated from embryonic stem cells, adult mesenchymal stem cells, and cardiac side population cells (cardiac stem cells). When these cells were injected into diseased hearts, indices of cardiac function improved. There are ethical difficulties involved in the use of embryonic stem cells. The ratio of differentiation into cardiomyocytes is still relatively low at present. Transplantation of regenerated cardiomyocytes or stem cells, however, will become a future therapy for severe heart failure.

AB - Emerging evidence indicates that cardiomyocytes can be regenerated from embryonic stem cells, adult mesenchymal stem cells, and cardiac side population cells (cardiac stem cells). When these cells were injected into diseased hearts, indices of cardiac function improved. There are ethical difficulties involved in the use of embryonic stem cells. The ratio of differentiation into cardiomyocytes is still relatively low at present. Transplantation of regenerated cardiomyocytes or stem cells, however, will become a future therapy for severe heart failure.

UR - http://www.scopus.com/inward/record.url?scp=7044269322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044269322&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 454

EP - 458

JO - Nihon Geka Gakkai zasshi

JF - Nihon Geka Gakkai zasshi

SN - 0301-4894

IS - 8

ER -